GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Dr Hoenle AG (XTER:HNL) » Definitions » Capex-to-Revenue

Dr Hoenle AG (XTER:HNL) Capex-to-Revenue : 0.01 (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Dr Hoenle AG Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Dr Hoenle AG's Capital Expenditure for the three months ended in Dec. 2023 was €-0.22 Mil. Its Revenue for the three months ended in Dec. 2023 was €23.79 Mil.

Hence, Dr Hoenle AG's Capex-to-Revenue for the three months ended in Dec. 2023 was 0.01.


Dr Hoenle AG Capex-to-Revenue Historical Data

The historical data trend for Dr Hoenle AG's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Hoenle AG Capex-to-Revenue Chart

Dr Hoenle AG Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 0.32 0.15 0.04 0.03

Dr Hoenle AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.01 0.02 0.03 0.01

Competitive Comparison of Dr Hoenle AG's Capex-to-Revenue

For the Electrical Equipment & Parts subindustry, Dr Hoenle AG's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dr Hoenle AG's Capex-to-Revenue Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Dr Hoenle AG's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Dr Hoenle AG's Capex-to-Revenue falls into.



Dr Hoenle AG Capex-to-Revenue Calculation

Dr Hoenle AG's Capex-to-Revenue for the fiscal year that ended in Sep. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-2.934) / 106.342
=0.03

Dr Hoenle AG's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.219) / 23.787
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dr Hoenle AG  (XTER:HNL) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Dr Hoenle AG Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Dr Hoenle AG's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Dr Hoenle AG (XTER:HNL) Business Description

Traded in Other Exchanges
Address
Nicolaus-Otto-Street 2, Gilching, Munich, BY, DEU, 82205
Dr Hoenle AG supplies industrial UV technology. It operates in three business segments: The Equipment and Systems segment, which accounts for the majority of revenue, includes devices for UVC air and surface disinfection, and it is used for drying inks and coatings, for curing adhesives and plastics, and for solar simulation. The Glass and Lamps segment includes the development, production, and sale of tubing and semi-finished goods made of quartz glass as well as the manufacture of UV medium?pressure and low-pressure lamps. Adhesives segment, which includes industrial adhesives designed for a broad spectrum of applications such as electronics, medical technology, optics, and glass processing. The company generates the majority of its revenue from sales in other countries.

Dr Hoenle AG (XTER:HNL) Headlines

No Headlines